Skip to main content
OpenTrials
Completed

NCT Number: NCT06214416

Pragmatic Clinical Trial of Two Recommendations Regarding Alcohol Consumption: a Pilot Study NAMETI_ALCOHOL

NAMETI-Alcohol, from the acronym for Navarra Medical Trialist Initiative, is a pilot study in which two patterns of alcohol consumption, abstention and Mediterranean alcohol-drinking pattern, and their effects on health in the short and medium term will be compared.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Navarra

Pamplona, Navarre, 31008, Spain

About this study

Background: Alcohol is the most consumed psychoactive substance in Spain. In 2016 it was the seventh leading risk factor for death and disability-adjusted lost years worldwide, and the first one in people between 15 and 49 years old.In the scientific community there is some controversy about what would be the best approach to face this great problem. On the one hand, there is evidence to recommend that there is no safe level of alcohol. However, on the other hand, there are studies that demonstrate the protective role of a moderate alcohol consumption. In this pilot study both options will be compared.

Methods: It is intended to recruit a total of 100 participants, including two observational cohorts of abstainers and drinkers. The intervention will be carried out in drinkers willing to change their alcohol consumption, divided into 2 groups of 50 participants, the abstention group and the Mediterranean alcohol-drinking pattern group. The Mediterranean alcohol-drinking pattern includes 5 aspects: moderate alcohol consumption (maximum of 1 drinks/day for women and 2 drinks/day for men), spread consumption throughout the week, drink with meals and never with an empty stomach, prefer wine and mainly red wine, as well as completely avoid episodes of binge-drinking. The main objective will be to compare the short and medium term effects on health of both patterns.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consuming more than 3 drinks a week (except for the abstention-control arm)

Exclusion criteria

  • Sever chronic disease (cancer, cardiovascular disease, chronic hepatitis and mental illness)
  • Pregnant women or breastfeeding
  • Family or personal history of addiction, alcoholism or alcohol abuse

Treatment and study plan

Abstention

Behavioral

All the intervention will be carried out online once a month for a year, focusing on nutritional, behavioral and scientific evidence aspects, that promote abstention.

Mediterranean alcohol-drinking pattern

Behavioral

All the intervention will be carried out online once a month for a year, focusing on nutritional, behavioral and scientific evidence aspects, that promote the Mediterranean alcohol-drinking pattern.

Primary outcomes

  1. Glucose (mg/dl)

    Time frame: 1 year

    Changes differences in glucose levels

  2. HDL-Cholesterol (mg/dl)

    Time frame: 1year

    Changes differences in HDL-Cholesterol levels

  3. Total cholesterol (mg/dl)

    Time frame: 1year

    Changes differences in total cholesterol levels

  4. Triglycerides (mg/dl)

    Time frame: 1 year

    Changes differences in triglycerides

  5. Alanine Aminotransferase (ALT) (IU/L)

    Time frame: 1 year

    Changes differences in ALT

  6. Aspartate transaminase (AST) (IU/L)

    Time frame: 1 year

    Changes differences in AST

  7. Gamma-glutamyltransferase (GGT) (IU/L)

    Time frame: 1 year

    Changes differences in GGT

  8. c-Reactive Protein (CRP) (mg/L)

    Time frame: 1 year

    Changes differences in CRP

  9. Blood pressure (mm Hg)

    Time frame: 1 year

    Changes differences in systolic and diastolic blood pressure

Secondary outcomes

  1. Mental health

    Time frame: 1 year

    Through Beck's questionnaire, Lobo's mini-cognitive exam (Mini-Mental State examination) and clock drawing test

  2. Weight (kg)

    Time frame: 1 year

    Changes in weight (kg)

  3. Adherence to the intervention

    Time frame: 1 year

    Levels of resveratrol in urine and hydroxytyrosol in plasma and urine

  4. Body Mass Index (BMI) (kg/m2)

    Time frame: 1 year

    Changes in BMI, assessed through weight(kg) and height (m) (BMI=Weight/(Height)^2

Sponsors and collaborators

Lead sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Other

Collaborators

  • Ministry of Health, Spain

Registry information

Official study title

Pragmatic Clinical Trial to Compare the Short and Medium Term Effects of Two Recommendations Regarding Alcohol Consumption: a Pilot Study NAMETI_ALCOHOL

Acronym: NAMETI_ALCOHOL

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Jan 19, 2024
Registry last updated
Jan 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.